HALEY SATTERFIELD: Open Payments
NPI 1639809346 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 53 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $240 |
| ARGENX US, INC. | 5 | $142 |
| CSL Behring | 4 | $113 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Lundbeck LLC | 2 | $54 |
| Cala Health, Inc. | 2 | $50 |
| Averitas Pharma Inc. | 2 | $49 |
| Biogen, Inc. | 1 | $27 |
Products named: VYVGART HYTRULO, UBRELVY, Hizentra, KESIMPTA, Symbravo, QULIPTA, HYQVIA, VYEPTI.
Industry payments across SC — which companies pay providers there.
